Literature DB >> 16904215

Lyme carditis: persistent local delayed enhancement by cardiac magnetic resonance imaging.

Peter Scott Munk, Stein Ørn, Alf Inge Larsen.   

Abstract

Lyme borreliosis (LB) is the most common tick-born disease in the Northern Hemisphere. During early disseminated Lyme disease cardiac manifestation can occur. We report a case of isolated Lyme myocarditis with transitory total atrioventricular (AV)-block and myocardial necrosis indicated by a rise in Troponin-T (TNT). Antibiotic treatment resulted in complete resolution of the AV-block, but a local epimyocardial contrast enhancement persisted as shown by cardiac magnetic resonance imaging (MRI).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904215     DOI: 10.1016/j.ijcard.2006.05.068

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

Review 1.  Lyme carditis--diagnosis, treatment and prognosis.

Authors:  Norbert Scheffold; Bernhard Herkommer; Reinhard Kandolf; Andreas E May
Journal:  Dtsch Arztebl Int       Date:  2015-03-20       Impact factor: 5.594

2.  Lyme carditis presenting as atrial fibrillation.

Authors:  Abir Zainal; Amir Hanafi; Ninad Nadkarni; Mahmood Mubasher; Deeraj Lingutla; Ryan Hoefen
Journal:  BMJ Case Rep       Date:  2019-04-29

Review 3.  Lyme Carditis: From Pathophysiology to Clinical Management.

Authors:  Cinzia Radesich; Eva Del Mestre; Kristen Medo; Giancarlo Vitrella; Paolo Manca; Mario Chiatto; Matteo Castrichini; Gianfranco Sinagra
Journal:  Pathogens       Date:  2022-05-15

4.  A Case of Lyme Carditis Presenting with Atrial Fibrillation.

Authors:  Peter J Kennel; Melvin Parasram; Daniel Lu; Diane Zisa; Samuel Chung; Samuel Freedman; Katherine Knorr; Timothy Donahoe; Steven M Markowitz; Hadi Halazun
Journal:  Case Rep Cardiol       Date:  2018-09-02

5.  Lyme carditis manifesting with sinoatrial exit block: a case report.

Authors:  Antonius Büscher; Florian Doldi; Lars Eckardt; Patrick Müller
Journal:  Eur Heart J Case Rep       Date:  2022-01-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.